HPV Vaccine Recommended for Boys: US Panel
0
comments

All boys aged 11-12 should get the HPV vaccine, which is already approved for use in girls, said the recommendations from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP).
"The HPV vaccine will afford protection against certain HPV-related conditions and cancers in males, and vaccination of males with HPV may also provide indirect protection of women by reducing transmission of HPV," it said in a statement.
A press conference to describe the recommendations was scheduled for 12:45 pm (1645 GMT).
If the CDC accepts the panel's recommendations, all insurance companies would be required to cover it. Vaccines against HPV are made by Merck and GlaxoSmithKline.
Kenneth Bromberg, Chairman of Pediatrics and director of the Vaccine Research Center at The Brooklyn Hospital Center, said increasing awareness of HPV's role in other diseases, such as head and neck cancers, has given a new push to consideration of vaccinating boys and girls.
"In a perfect world, immunization of all girls might be the most cost-effective way of preventing HPV disease in women," he said.
"However, since we do not live in a perfect world, a very strong argument can be made for immunizing boys in order to prevent genital warts in males and the prevalence of HPV-related cancers in both boys and girls."